Related by context. All words. (Click for frequent words.) 76 5FU 74 cisplatin carboplatin 74 cisplatin 73 pegylated liposomal doxorubicin 73 adriamycin 72 docetaxel chemotherapy 72 paclitaxel Taxol 71 idarubicin 71 daunorubicin 71 topotecan 71 cyclophosphamide 70 fluorouracil 70 Cisplatin 70 erlotinib Tarceva ® 70 chemotherapy regimens 70 docetaxel Taxotere 70 CHOP chemotherapy 70 sorafenib Nexavar 70 mitoxantrone 69 azacytidine 69 bleomycin 69 doxorubicin 69 gemcitabine 69 liposomal doxorubicin 69 gemcitabine Gemzar 69 bendamustine 69 Etoposide 69 oblimersen 69 standard chemotherapy regimen 69 epirubicin 69 nab paclitaxel 69 concurrent chemoradiation 69 Fludarabine 69 imetelstat 69 Irinotecan 69 Pemetrexed 69 Doxil ® 69 gemcitabine carboplatin 69 temozolomide 69 ritonavir boosted 69 cyclophosphamide methotrexate 69 gemcitabine cisplatin 69 cisplatin gemcitabine 68 Trastuzumab 68 thalidomide Thalomid 68 cytarabine 68 Platinol ® cisplatin 68 decitabine 68 gefitinib Iressa 68 alkylating agent 68 pegfilgrastim 68 vinorelbine 68 TACE 68 sorafenib Nexavar ® 68 FOLFIRI 68 temozolomide TMZ 68 carboplatin paclitaxel 68 bevacizumab Avastin ® 68 5 FU 68 azacitidine 68 Gemcitabine 68 mitomycin 68 estramustine 68 cisplatin chemotherapy 68 imatinib Gleevec 68 xenograft models 67 mycophenolate mofetil 67 taxane chemotherapy 67 relapsed MM 67 docetaxel 67 Fludara 67 olmesartan 67 rituximab 67 vincristine 67 chemotherapeutic drug 67 chemotherapeutic regimen 67 chemotherapy cisplatin 67 trans retinoic acid 67 milatuzumab 67 cytotoxic chemotherapy 67 5 Fluorouracil 67 5 FU leucovorin 67 gemcitabine Gemzar ® 67 pemetrexed 67 intravesical 67 sorafenib 67 imatinib therapy 67 erlotinib 67 dasatinib Sprycel 67 flavopiridol 67 mapatumumab 67 cetuximab Erbitux ® 66 chemotherapeutic regimens 66 IFN α 66 NOD SCID mice 66 cytotoxic 66 chemoradiotherapy 66 dexamethasone Decadron 66 chemotherapeutic 66 radiotherapy RT 66 mTOR inhibitors 66 ibritumomab tiuxetan 66 pertuzumab 66 standard chemotherapy regimens 66 BEACOPP 66 bevacizumab Avastin R 66 Taxotere docetaxel 66 trastuzumab 66 chlorambucil 66 5 fluorouracil 66 CA4P 66 metastatic malignant 66 MGd 66 cetuximab Erbitux R 66 interferon alfa 66 leucovorin 66 VNP#M 66 arsenic trioxide 66 anti angiogenic agents 66 paclitaxel chemotherapy 66 5-FU/LV 66 fluvastatin 66 vitro cytotoxicity 66 lenalidomide Revlimid 66 ara C 66 chemotherapy docetaxel 66 FUSILEV enhances 66 Cloretazine 66 pyrazinamide 66 dose dexamethasone 66 cyclophosphamide doxorubicin vincristine 66 lenalidomide dexamethasone 66 alpha 2a 66 Xanafide 66 chemotherapeutic agents 66 oral clodronate 66 relapsed ovarian cancer 66 Peg IFN 66 FOLFOX4 66 trastuzumab Herceptin ® 66 Cytoxan 66 cilengitide 66 sunitinib malate 66 isoproterenol 66 lapatinib Tykerb 65 bortezomib 65 Taxotere ® 65 Pegylated Interferon 65 Pharmacokinetics PK 65 dose cytarabine 65 intratumoral injection 65 docetaxel Taxotere ® 65 trans retinoic acid ATRA 65 dosed orally 65 doxorubicin cyclophosphamide 65 fulvestrant 65 interferon alfa 2a 65 dacarbazine 65 interferon IFN 65 Camptosar ® 65 irinotecan doxorubicin oxaliplatin paclitaxel 65 histone deacetylase inhibitor 65 Epirubicin 65 relapsed refractory 65 fibrinolytic 65 inhibitory effects 65 GRN#L 65 xenograft tumors 65 Gefitinib 65 busulfan 65 gemcitabine chemotherapy 65 DOXIL 65 fluoropyrimidine 65 cisplatin resistant 65 vinca alkaloid 65 bortezomib Velcade 65 colon carcinoma 65 erythropoietic 65 Pertuzumab 65 lenalidomide Revlimid R 65 Cyclophosphamide 65 paricalcitol 65 trastuzumab Herceptin R 65 vorinostat 65 antithymocyte globulin 65 corticosteroid dexamethasone 65 chemotherapeutic agent 65 chemoresistance 65 paclitaxel 65 letrozole Femara 65 DAPT 65 effector function 65 Cytarabine 65 ribavirin RBV 65 hepatoma 65 protein kinase inhibitor 65 chemotherapies 65 chemotherapy regimen 65 Vidaza ® 65 paclitaxel carboplatin 65 Gleevec resistant 65 HDACi 65 pomalidomide 65 tyrosine kinase inhibitor 65 IFN alpha 65 immunomodulatory therapy 65 TNF α 65 intratumoral 65 postoperative chemotherapy 65 Neulasta ® 65 FOLFOX chemotherapy 65 paclitaxel Taxol ® 65 SCCHN 65 Capecitabine 65 immunomodulator 65 melphalan prednisone 64 VAPRISOL 64 pamidronate 64 PEGPH# 64 docetaxel Taxotere R 64 radiochemotherapy 64 immune modulating 64 pegylated interferon alfa 64 receptor tyrosine kinase inhibitor 64 galiximab 64 neoadjuvant chemotherapy 64 demethylating agent 64 refractory NSCLC 64 #mg/m# [001] 64 chemotherapeutic drugs 64 interferon ribavirin 64 alfa 2a 64 oxaliplatin 64 administered subcutaneously 64 dose cyclophosphamide 64 farletuzumab 64 sunitinib 64 mononuclear 64 temsirolimus 64 telaprevir dosed 64 CsA 64 FOLFOX6 64 carmustine 64 intravesical instillation 64 MabCampath 64 ABVD 64 liposomal formulation 64 trabectedin 64 cetuximab 64 Ontak 64 G CSF 64 anti leukemic 64 rituximab Rituxan 64 nucleoside analog 64 HGS# 64 antitumor 64 4mg/kg 64 darunavir ritonavir 64 cediranib 64 Neupogen ® 64 platelet inhibitor 64 imatinib 64 L asparaginase 64 steroid dexamethasone 64 LHRH agonist 64 antiangiogenic therapy 64 alkylating agents 64 gemtuzumab ozogamicin 64 Platinol 64 HER2 positive metastatic breast 64 GHRH 64 antitumor effect 64 Azacitidine 64 cyclophosphamide chemotherapy 64 bortezomib Velcade R 64 LHRH receptor positive 64 sorafenib tablets 64 dasatinib Sprycel ® 64 bevacizumab Avastin 64 FOLPI 64 octreotide LAR 64 OMP #M# 64 goserelin 64 zoledronate 64 antiangiogenic 64 Copegus ribavirin 64 antiandrogen 64 depsipeptide 64 Doxorubicin 64 Gliadel Wafer 64 imatinib resistant 64 PegIFN 64 Vincristine 64 calcitriol 64 ONCASPAR 64 DFMO 64 PEG IFN 64 APTIVUS 64 low dose cytarabine 64 uM 64 papillary renal cell carcinoma 64 Bortezomib 64 metastatic renal cell carcinoma 64 Taxol ® 64 piperacillin tazobactam 64 CYT# potent vascular disrupting 64 Carboplatin 64 cytarabine daunorubicin 63 Imprime PGG 63 denileukin diftitox 63 pancreatic adenocarcinoma 63 orally dosed 63 Fluorouracil 63 mutated KRAS 63 nelfinavir 63 fosamprenavir 63 APTIVUS r 63 dexamethasone 63 neoadjuvant 63 zoledronic acid 63 rituximab Rituxan ® 63 6 mercaptopurine 63 cytotoxicity 63 Folfox 63 PSMA ADC 63 Doxil 63 chemotherapy FOLFOX 63 Akt activation 63 Panzem R NCD 63 baseline LDH 63 cytostatic 63 favorable pharmacokinetic profile 63 chemotherapeutics 63 flutamide 63 myeloablative 63 superficial bladder cancer 63 tirofiban 63 visilizumab 63 uric acid lowering 63 trastuzumab Herceptin 63 interferon alfa 2b 63 fludarabine cyclophosphamide 63 sunitinib Sutent 63 infusional 63 carboplatin 63 antiapoptotic 63 Oxaliplatin 63 hepatic metastases 63 chemoradiation 63 overlapping toxicities 63 FOLFOX6 chemotherapy regimen 63 cyclophosphamide Cytoxan 63 dose melphalan 63 CLL SLL 63 tenecteplase 63 heavily pretreated patients 63 mycophenolate mofetil MMF 63 Fulvestrant 63 ovarian carcinoma 63 #mg/m# [002] 63 bicalutamide 63 paclitaxel cisplatin 63 erlotinib Tarceva 63 tyrosine kinase inhibitors 63 Docetaxel 63 pharmacologically active isomer 63 DOXIL ® 63 vinblastine 63 endostatin 63 pegylated interferon alpha 63 Vidofludimus 63 amprenavir 63 #beta estradiol 63 raltegravir 63 irbesartan 63 Paraplatin ® carboplatin 63 AZT zidovudine Retrovir 63 Hycamtin ® 63 taxanes 63 Alkeran 63 Ibritumomab Tiuxetan 63 recombinant erythropoietin 63 Taxotere chemotherapy 63 myelosuppressive 63 conventional DMARDs 63 Velcade bortezomib 63 erythropoiesis 63 irinotecan chemotherapy 63 K ras mutations 63 RRM1 63 Temozolomide 63 albumin bound paclitaxel 63 caspofungin 63 chemoradiation therapy 63 EGFR expressing 63 teriflunomide 63 YONDELIS 63 EGFR tyrosine kinase inhibitors 63 isoenzyme 63 coadministration 63 huN# DM1 63 bevacizumab 63 ganciclovir 63 HGS ETR1 63 VEGF inhibitors 63 adalimumab Humira 63 fosbretabulin 63 abacavir lamivudine 62 potentially hepatotoxic 62 Amrubicin 62 intravenously administered 62 EBRT 62 debulking surgery 62 TNFalpha 62 paclitaxel Taxol R 62 alefacept 62 sevelamer 62 IL 1ß 62 Chemophase 62 antimetabolite 62 mRCC 62 iodixanol 62 intraperitoneal injection 62 octreotide 62 azathioprine 62 Anthracycline 62 bacillus Calmette Guerin 62 Interferon beta 62 #F FDG 62 Bevacizumab 62 mCRC patients 62 antifolates 62 factor G CSF 62 AMD# [003] 62 xanthine oxidase inhibitor 62 nucleoside analogs 62 prednisone prednisolone 62 anthracycline chemotherapy 62 DAVANAT 62 fallopian tube cancers 62 Interferon alfa 62 acute GvHD 62 PC3 cells 62 HCV replicon 62 nicardipine 62 Cremophor 62 reteplase 62 protease inhibitor PI 62 amrubicin 62 transgene expression 62 fludarabine 62 Leucovorin 62 camptothecin 62 amphotericin B 62 mg kg dose 62 GSTP1 62 Telintra 62 APTIVUS R 62 nonmyeloablative 62 cidofovir 62 Diffuse Large B 62 Rituxan rituximab 62 Navelbine ® 62 TTF Therapy 62 Elitek 62 peginterferon alpha 2a 62 chemo radiotherapy 62 tegafur 62 systemic antifungal 62 clodronate 62 ascending dose 62 LHRH agonists 62 external beam radiotherapy 62 epoetin beta 62 Caelyx 62 receptor blocker 62 FOLFOX 62 pentamidine 62 tenofovir Viread 62 cytotoxic effects 62 molecularly targeted 62 antitumor activity 62 neurologic progression 62 GW# [003] 62 intravenous dosing 62 IAP inhibitor 62 dextran 62 Blinatumomab 62 pegylated interferon alfa 2a 62 TRAIL induced apoptosis 62 BCG refractory 62 rFSH 62 chemoembolization 62 cyclophosphamide doxorubicin 62 antitumor effects 62 #I TM# 62 Mitomycin C 62 Fludara ® 62 PI3K Akt 62 Peginterferon 62 Seliciclib 62 immunoconjugate 62 tumor xenograft models 62 demonstrated antitumor activity 62 anastrazole 62 TNFa 62 irinotecan 62 vWF 62 IFN beta 62 boosted protease inhibitor 62 pharmacodynamic profile 62 pro angiogenic 62 hA# 62 aspirin clopidogrel 62 Paraplatin ® 62 syngeneic 62 Dacogen decitabine 62 NRTIs 62 TKI therapy 62 M1 muscarinic 62 doxorubicin Adriamycin 62 elastase 62 EGFR TKIs 62 ixabepilone 62 ceftazidime 62 inotropic 62 Everolimus 62 cyclophosphamide vincristine 62 genotypic resistance 62 prostate carcinoma 62 dasatinib 62 cytotoxic agents 62 HepG2 cells 62 mitoxantrone plus 62 oral levofloxacin 62 bortezomib Velcade ® 62 epirubicin cyclophosphamide 62 FLT3 ITD 62 Flu Cy 62 ZD# [001] 62 IFN gamma 62 subcutaneous SC 62 N acetylcysteine 62 ELOXATIN 62 nanomolar range 62 melphalan 62 ULORIC 62 oral antiviral 62 GPIIb IIIa 62 comparator arm 62 fibrinolysis 62 TMC# r 62 Mitoxantrone 62 anthracycline taxane 62 CIMZIA TM 62 amikacin 62 receiving VICTRELIS 62 deferoxamine 62 PegIFN RBV 62 sargramostim 62 Pegylated Liposomal Doxorubicin 62 posaconazole 62 Vidaza azacitidine 62 radiolabeled 62 Taxol paclitaxel 62 VIDAZA 62 heparanase 62 Platinol ® 62 vandetanib 62 ERK1 2 62 3TC lamivudine Epivir 62 enzastaurin 62 lung metastases 62 nanomolar 62 EGFR mutant 62 chemotherapy gemcitabine 62 epithelial tumors 62 leflunomide 62 induced apoptosis 62 transfected 62 EGF receptor 61 weekly subcutaneous injections 61 orally administered inhibitor 61 Omacetaxine 61 induce remission 61 PARP inhibitor 61 pegylated interferon alfa 2b 61 Lenalidomide 61 Neoadjuvant 61 folinic acid 61 daily subcutaneous injections 61 relapsed CLL 61 cis retinoic acid 61 anti proliferative 61 antiproliferative activity 61 idraparinux 61 capecitabine Xeloda 61 metaglidasen 61 taxol 61 CANCIDAS 61 anti angiogenic agent 61 Navelbine 61 MYLOTARG 61 meropenem 61 interleukin IL -# 61 thiazide diuretic 61 Pegasys ® 61 HSP# inhibitor 61 angiogenesis inhibitor 61 Rituximab 61 leukemia AML 61 proteasome inhibitors 61 fluorouracil leucovorin 61 intravenous cyclophosphamide 61 Imatinib 61 peginterferon alfa 2b 61 infusional 5-FU/LV 61 Tarceva TM 61 lanthanum carbonate 61 rFVIIa 61 5 fluorouracil leucovorin 61 iNOS 61 NRTI 61 biochemical relapse 61 imatinib Gleevec ® 61 multikinase inhibitor 61 receptor antagonists 61 PI3K inhibitor 61 Interferon alpha 61 colony stimulating factors 61 eplerenone 61 monotherapy 61 Carfilzomib 61 liposomal amphotericin B 61 TEMODAL 61 Vinorelbine 61 cinacalcet 61 cyclosporin 61 tipranavir 61 refractory chronic lymphocytic 61 arsenic trioxide ATO 61 recurrent glioblastoma multiforme 61 epoetin alfa 61 seliciclib 61 eptifibatide 61 μg dose 61 ERBB2 61 antiangiogenic agent 61 talabostat 61 ISF# 61 CDK inhibitor 61 PKC# 61 MYCAMINE 61 subcutaneously injected 61 IIIa inhibitor 61 cytotoxic therapies 61 TAXOTERE R 61 EGFR HER2 61 IMC A# 61 Orally administered 61 paclitaxel poliglumex 61 adjuvant radiotherapy 61 IFN alfa 61 rhEPO 61 vincristine doxorubicin 61 palifermin 61 gamma secretase inhibitor 61 targeted antifolate 61 microtubule inhibitor 61 hydroxychloroquine 61 indinavir 61 antidiabetic 61 cell lymphoma CTCL 61 NMIBC 61 luteinizing hormone releasing 61 pDC 61 colorectal liver metastases 61 histone deacetylase HDAC inhibitor 61 CIMZIA ™ 61 mol L 61 evaluating tivozanib 61 AKT inhibitor 61 granulocyte colony stimulating 61 selective inhibition 61 TIMP 1 61 Enzastaurin 61 heavily pretreated 61 pro apoptotic 61 Dasatinib 61 tumor regressions 61 plus ribavirin 61 FluCAM 61 atazanavir ritonavir 61 c MYC 61 fondaparinux 61 CD# monoclonal antibody 61 platinum refractory 61 Arsenic trioxide 61 pDCs 61 Triapine R 61 nilotinib Tasigna 61 dosage regimens 61 plasma uric acid 61 ER CHOP 61 mg/m2 dose 61 epirubicin cisplatin 61 lymphoid malignancies 61 mTOR mammalian target 61 Angiotensin Converting Enzyme 61 allogeneic SCT 61 vasodilatory 61 cytoprotective 61 corifollitropin alfa 61 VELCADE melphalan 61 doxorubicin docetaxel 61 intermittent dosing 61 mecamylamine 61 injected subcutaneously 61 induces apoptosis 61 Bleomycin 61 mitomycin C 61 inhibitor RG# 61 peginterferon alfa 2a Pegasys 61 IGFBP 3 61 refractory ovarian cancer 61 Degarelix 61 inducible nitric oxide synthase 61 proteasome inhibitor bortezomib 61 DNA intercalator 61 eribulin mesylate 61 tacrolimus 61 EGFr 61 certolizumab 61 hypomethylating agents 61 lopinavir r 61 BRAF inhibitor 61 REYATAZ R 61 mutational status 61 sulfasalazine 61 neoadjuvant therapy 61 Nilotinib 61 RAS mutations 61 peg interferon 61 pharmacodynamics PD 61 Revlimid lenalidomide 61 ethambutol 61 fallopian tube carcinoma 61 HMG CoA reductase inhibitors 61 HER2 receptor 61 forskolin 61 Anti Bacterial Envelope 61 active comparator 61 GnRH agonist 61 Taxotere R 61 Gleevec imatinib mesylate 61 HSCT 61 veltuzumab 61 nucleoside analogues 61 Panzem NCD 61 rFVIII 61 Ceplene/IL-2 61 tamoxifen Nolvadex ® 61 TNF Tumor Necrosis Factor 61 immunosuppressant 61 TGF beta1 61 Cytotoxic 61 peripheral blood mononuclear 61 preoperative chemotherapy 61 mRNA expression 61 rhIL 7 61 allogeneic transplant 61 intravenous bisphosphonates 61 beta 1a 61 transarterial 61 saline placebo 61 placebo dexamethasone 61 ENMD # 61 autologous SCT 61 vinca alkaloids 61 antitumor efficacy 61 LEXIVA r 61 xenograft model 61 LEXIVA 61 Tumor Necrosis Factor 61 NF kappaB activation 61 pharmacokinetic interactions 61 Erlotinib 61 low dose ritonavir 61 Omacetaxine mepesuccinate 61 Zoledronic acid 61 CLL cells 61 angiotensin receptor blocker ARB 61 Immunohistochemical analysis 61 androgen dependent 61 anti angiogenic 61 mediated apoptosis 61 LHRH 61 Combination therapy 61 BAY #-# 61 alkylating 61 PEG SN# 61 ZOLINZA 61 Tarceva erlotinib 61 nadolol 61 oral allopurinol 61 FOSRENOL ® 61 potent antiproliferative 61 hypoxia inducible factor 61 Sorafenib 61 prednisone CHOP 61 DMARDs 61 bolus dose 61 gefitinib 61 sunitinib Sutent ® 60 novel VDA molecule 60 taxotere 60 iniparib 60 Annamycin 60 CD# expressing 60 plus 5-FU/LV 60 dalteparin 60 Vorinostat 60 Xeloda ® 60 relapsed multiple myeloma 60 VEGFR2 60 5alpha reductase 60 rosuvastatin #mg 60 timolol 60 SCH # 60 selective modulator 60 colorectal cancer liver metastases 60 haematopoietic 60 glioma cells 60 sorafenib Nexavar R 60 alpha interferons 60 Bezielle 60 Xelox 60 dose ritonavir 60 AQ4N 60 Hycamtin 60 Gemzar gemcitabine 60 enzyme inhibitor 60 radiation chemoradiation 60 GnRH agonists 60 breast carcinoma 60 oral Hycamtin 60 chimeric monoclonal antibody 60 lymphoid cells 60 kinase inhibition 60 lytic 60 etanercept Enbrel 60 metastatic neuroendocrine tumors 60 Sanofi Aventis Taxotere 60 CD# + [002] 60 rHuEPO 60 castrate resistant 60 Eli Lilly Gemzar 60 pan HDAC inhibitor 60 zalutumumab 60 abciximab 60 plus prednisone 60 anticancer treatments 60 mTOR inhibitor 60 receptor inhibitor 60 PREZISTA rtv 60 saquinavir ritonavir 60 TPV r 60 cytotoxicity assays 60 pharmacodynamic endpoints 60 sirolimus 60 receptor blockers 60 liposome formulation 60 pimozide 60 myopathy rhabdomyolysis 60 monocyte chemotactic protein 60 immuno modulatory 60 serum cortisol 60 leukemia CLL 60 antiproliferative 60 tiuxetan 60 docetaxel cisplatin 60 radiolabeled monoclonal antibody 60 pyridostigmine 60 cisplatin vinorelbine 60 CBLC# 60 cytoreduction 60 EGFR 60 MDS AML 60 TELINTRA 60 androgen blockade 60 mutated K ras 60 V#F mutation 60 p# MAP kinase inhibitor 60 nilotinib 60 Aplidin 60 ErbB2 positive 60 Tumor Response 60 allogeneic stem cell 60 azoles 60 MetMAb 60 endoxifen 60 EGFR TKI 60 #mg dose [001] 60 bolus injection 60 anticancer activity 60 microtubule targeting 60 ® lenalidomide 60 adefovir 60 Preclinical studies 60 db db mice 60 glucose lowering 60 resistant ovarian cancer 60 cefuroxime 60 HMG CoA reductase inhibitor 60 locoregional 60 glioblastoma cells 60 Elotuzumab 60 AEGR 60 q8h 60 adjuvant cisplatin 60 Toxicities 60 orthotopic 60 Gemzar ® 60 Decitabine 60 μg ml 60 pathophysiological effects 60 angiotensin converting enzyme inhibitor 60 thymidine 60 oxaliplatin Eloxatin 60 antiproliferative effects 60 basiliximab 60 colorectal carcinoma 60 microwave hyperthermia 60 histone deacetylases 60 PC# cells 60 dose dependently 60 CD8 + cytotoxic 60 rt PA 60 chronic lymphocytic leukemia CLL 60 platelet reactivity 60 partial remissions 60 Fenretinide 60 peg IFN 60 Alocrest 60 temozolomide Temodar 60 selectively inhibits 60 neratinib 60 multitargeted 60 kinase inhibitor 60 antineoplastic 60 experimental autoimmune encephalomyelitis 60 ISTODAX 60 TG# [003] 60 selective agonist 60 leukemic stem cells 60 Preclinical studies suggest 60 metastatic colorectal 60 immune suppressive 60 tipranavir ritonavir 60 tubulin binding 60 pegylated 60 inhibited tumor 60 proteasome inhibitor 60 nucleoside reverse transcriptase inhibitors 60 leukemic cell 60 immunosuppressive agents 60 Vaprisol 60 Immunomodulatory 60 TO AVOID PREGNANCY WHILE 60 immunosuppressant drug 60 hepatocellular carcinomas 60 Darunavir 60 immune modulator 60 voriconazole 60 biologic DMARD 60 mononuclear cells 60 colorectal tumor 60 viral kinetics 60 Myocet 60 LTB4 60 CD4 + CD# 60 Teriflunomide 60 taxane therapy 60 ZACTIMA 60 amifostine 60 tinidazole 60 Losartan 60 somatostatin analogues 60 EGFR inhibitors 60 phorbol 60 BMS # 60 Imiquimod 60 Immunohistochemical staining 60 fluticasone furoate 60 ^ sup #m 60 metformin sulfonylurea 60 plus prednisone prednisolone 60 dosing regimens 60 oral chemotherapeutic agent